Home > Cashflow Statement > BETA DRUGS

BETA DRUGS
Net Cash Inflow / Outflow

    Back to Cashflow Statement
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Net Cash Inflow / Outflow History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Cash Inflow / Outflow ₹-22 Cr₹118 Cr₹9.47 Cr₹1.84 Cr₹6.90 Cr

What is the latest Net Cash Inflow / Outflow ratio of BETA DRUGS ?

The latest Net Cash Inflow / Outflow ratio of BETA DRUGS is ₹-22 Cr based on Mar2026 Consolidated results.
Year Net Cash Inflow / Outflow
Mar2026₹-22 Cr
Mar2025₹118 Cr
Mar2024₹9.47 Cr
Mar2023₹1.84 Cr
Mar2022₹6.90 Cr

How is Net Cash Inflow / Outflow of BETA DRUGS Trending?

Years Net Cash Inflow / Outflow % Change
Mar2026 ₹-22 Cr
Negative
Mar2025 ₹118 Cr
1,150.30
Mar2024 ₹9.47 Cr
414.62
Mar2023 ₹1.84 Cr
-73.33
Mar2022 ₹6.90 Cr -

Compare Net Cash Inflow / Outflow of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,076.8 Cr 1.7% 1.5% 8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 3.9% 7.8% 13% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 11.5% 20.6% 68% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1.1% 11.8% 14.9% Stock Analytics
CIPLA ₹114,478.0 Cr 1.1% 7.9% -6.3% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

1.7%

1.5%

8.1%

SENSEX

5.9%

13%

-1.9%


You may also like the below Video Courses